Mar 25 |
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 18 |
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
|
Feb 26 |
12 $10 Stocks That Will Triple
|
Feb 26 |
Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference
|
Feb 8 |
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript
|
Feb 7 |
Anavex Life Sciences Corp. (AVXL) Q1 2024 Earnings Call Transcript
|
Feb 7 |
Anavex Life Sciences GAAP EPS of -$0.11 beats by $0.04
|
Feb 7 |
Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update
|
Feb 7 |
Earnings Scheduled For February 7, 2024
|
Feb 6 |
Anavex Life Sciences Q1 2024 Earnings Preview
|